FMP
Blue Water Vaccines, Inc.
BWV
NASDAQ
Inactive Equity
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
0.18 USD
-0.0135 (-7.49%)
About
ceo
Dr. Neil J. Campbell MA, MBA
sector
Healthcare
industry
Biotechnology
website
https://www.bluewatervaccines.com
exchange
NASDAQ
Description
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
CIK
0001782107
ISIN
US09610B1089
CUSIP
09610B108
Address
201 East Fifth Street
Phone
513 620 4101
Country
US
Employee
12
IPO Date
Feb 18, 2022
Key Executives
